FANCL的美白增强成分促进转运蛋白的表达

FANCL公司于2004年3月推出的“White Advance”是通过口服可消除皮肤斑点的美白保健食品。     

MicroRNA介导中药活性成分抗肿瘤机制的研究进展

MicroRNA(miRNA)作为一类新发现的非编码RNA,其异常表达在肿瘤的病理过程中扮演着重要角色,起着类似癌基因和抑癌基因的双重作用。目前中药活性成分抗肿瘤已成为关注的热点,但其影响miRNA的报道却较少。就近几年有关中药活性成分、miRNA及肿瘤间关系的研究进行了综述,为今后中药活性成分抗肿瘤的机制研究提供新思路。     

温莪术药渣再提取工艺及其美白活性研究CSCD

以活性成分总姜黄素得率为指标,响应面法优化温莪术药渣的最佳提取工艺,采用DPPH法和ABTS法评价温莪术药渣提取物的抗氧化活性,并考察其对小鼠黑色素瘤B16细胞存活率、黑色素合成及其细胞内酪氨酸酶活性的影响。实验结果表明,温莪术药渣提取物的最佳工艺条件为乙醇浓度82%,超声时间55 min,液料比22 mL/g,总姜黄素平均提取得率为6.38 mg/g;此外,温莪术药渣提取物对DPPH、ABTS自由基具有一定的清除作用,IC_(50)值分别为24.99、49.72μg/mL;并且能有效抑制B16细胞黑色素合成及酪氨酸酶活性,与正常组相比均具有显著性差异(P<0.05)。本研究为温莪术提油后药渣二次开发利用提供了依据。     

合成生物学促进中药活性成分的生物合成

中药是我国的传统药物,现也在不断地谋求发展和创新。合成生物学可以通过“模块化”和“适配性”方法将代谢产物或其前体的生物合成过程从植物转移至微生物中,通过发酵生产中药的活性成分。本文综述了现有中药合成的方法,阐述了合成生物学对中药活性成分合成的促进作用。     

太子参粗提物抗氧化性及护肤功效分析

比较三种不同萃取方式对太子参Pseudostellaria heterophylla粗提物抗氧化、美白、保湿等方面的影响。结果显示,在ABTS和DPPH自由基及细胞内活性氧(ROS)抑制率分析中,以水萃方式所得粗提物的抑制效果最佳,优于醇萃取及超临界流体萃取。在美白功效方面,B16细胞黑色素含量抑制率以醇萃物最佳,酪氨酸酶活性抑制率则以水萃物最佳。进一步萃取太子参粗多糖体分析其保湿及吸湿效果,结果显示太子参粗多糖体具有良好的保湿及吸湿功效,其效果与透明质酸相近,应用于皮肤水分散失率评估,也具有显著的预防功效。     

丹参活性成分的现代中药药理研究进展

对传统中药丹参中丹参酮、丹酚酸、丹参单体IH764-3三种主要活性成分及其近年来的中药药理学研究进展进行综述,为进一步开发利用这一传统中药提供理论依据。     

微量液基稀释法测定中药活性成分的体外抗曲霉菌活性*

通过测定中药活性成分肉桂醛和柠檬醛对常见深部条件致病性真菌黄曲霉、烟曲霉的抗菌活性,为建立中药抗曲霉菌药敏试验标准提供参考依据。参照美国国家临床试验标准化委员会(National Committee for Clinical Laboratory Standards,NCCLS)提出的标准,用微量液基稀释法分别测定肉桂醛和柠檬醛对黄曲霉、烟曲霉的抗菌活性。肉桂醛对黄曲霉、烟曲霉最低抑菌浓度(Minimal inhibitory concentration,MIC)分别为：0.100μg/mL,0.050μg/mL,柠檬醛对黄曲霉、烟曲霉的MIC分别为：2．600μg/mL、0．650μg/mL。中药活性成分肉桂醛和柠檬醛具有高效抗曲霉作用。该研究可为制定中药抗曲霉作用评价标准提供参考依据。     

中药郁金挥发油成分及挥发油中蜡质成分研究

对中药郁金挥发油成分进行ＧＣ－ＭＳ－ＤＳ分析,共分离得到１３７个气相色谱峰,鉴定出７３种成分,其中３６种为首次鉴定出。首次,作者对其挥发油中蜡质成分进行分离,经ＧＣ－ＭＳ－ＤＳ分析得其主要成分为长直链烷烃和长直链脂肪酸。     

贝莱斯芽胞杆菌HN-Q-8菌株发酵液稳定性测定及抑菌活性成分分析

【背景】贝莱斯芽胞杆菌(Bacillus velezensis) HN-Q-8菌株是本实验室前期获得的能有效拮抗立枯丝核菌(Rhizoctonia solani)的生防细菌。【目的】明确贝莱斯芽胞杆菌HN-Q-8菌株的抑菌活性物质。【方法】采用菌丝生长速率法检测其发酵液对5种马铃薯病原菌的拮抗能力以及稳定性,利用基质辅助激光解吸电离飞行时间质谱技术对HN-Q-8菌株活性物质进行鉴定。【结果】HN-Q-8菌株对立枯丝核菌(Rhizoctonia solani)、尖镰孢菌(Fusarium oxysporum)、茄链格孢(Alternaria solani)和致病疫霉(Phytophthora infestans)具有良好的抑菌活性,抑菌率可达50%-90%。发酵液分别经紫外照射35min、自然光照射10 h以及100°C高温处理后,相对抑菌率分别为74%、92%和98%;发酵液的抑菌活性不受胰蛋白酶和蛋白酶K的影响;但不耐强酸、强碱,其适宜pH为4.0-10.0,表明HN-Q-8菌株活性物质具有良好的稳定性。活性成分能使立枯丝核菌菌丝形态畸形扭曲,从而抑制立枯丝核菌的生长,经鉴定活性物质...     

冬虫夏草活性成分研究进展

本文系统综述了冬虫夏草Cordyceps sinensis的主要化学组成和药理学作用研究进展,重点对冬虫夏草多糖、核苷、肽类和甾醇的研究成果进行了总结,同时也针对有关冬虫夏草的一些问题进行了客观评述,为深入研究其有效成分与虫草相关新药物研发提供了依据和思路.     

Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth

Recovery of therapeutic protein from high cell density yeast fermentations at commercial scale is a challenging task. In this study, we investigate and compare three different harvest approaches, namely centrifugation followed by depth filtration, centrifugation followed by filter-aid enhanced depth filtration, and microfiltration. This is achieved by presenting a case study involving recovery of a therapeutic protein from Pichia pastoris fermentation broth. The focus of this study is on performance of the depth filtration and the microfiltration steps. The experimental data has been fitted to the conventional models for cake filtration to evaluate specific cake resistance and cake compressibility. In the case of microfiltration, the experimental data agrees well with flux predicted by shear induced diffusion model. It is shown that, under optimal conditions, all three options can deliver the desired product recovery ( >80%), harvest time ( <15 h including sequential concentration/diafiltration step), and clarification ( <6 NTU). However, the three options differ in terms of process development time required, capital cost, consumable cost, ease of scale-ability and process robustness. It is recommended that these be kept under consideration when making a final decision on a harvesting approach.     

大孔树脂分离纯化蛹虫草深层发酵液中虫草素的工艺研究

通过比较10种不同大孔树脂吸附蛹虫草深层发酵液中虫草素的性能,筛选出合适的大孔树脂H103,并对大孔树脂H103的吸附和解吸条件进行了考察。实验结果表明,上样吸附前调节pH值为9,上样浓度为0．2mg·mL^-1,吸附流速为2BV·h^-1时,大孔树脂H103对蛹虫草深层发酵液中的虫草素有良好的吸附性能;解吸时先用去离子水洗去部分杂质,再用40％的乙醇对虫草素进行洗脱,可以得到较好的效果。     

Extracellular enzyme loss during polyelectrolyte flocculation of cells from fermentation broth

Association of extracellular protein product with flocculated cells reduces product yield. Here, partitioning of the enzyme subtilisin between the liquid and polyelectrolyte-flocculated and sedimented Bacillus increased as the polymer dosage was increased beyond that necessary to obtain optimum floc character (brain floc) for cell removal by centrifugation. Partitioning to the cell floc is partly physical entrapment at all polymer dosages; however, at higher levels there is also direct interaction between the polyelectrolyte and enzyme. Enzyme loss was not likely due to pH denaturation during the flocculation process because conditions were within the stable pH range of the enzyme. The direct interaction between polyelectrolyte and enzyme was characterized through turbidimetric titrations and partitioning studies. Neither changes in the polymer feed concentration nor the method of polymer addition reduced the enzyme loss at dosages optimal for cell removal.     

Emulsion liquid membrane extraction of lactic acid from aqueous solutions and fermentation broth

Studies on the batch extraction of lactic acid using an emulsion liquid membrane system are reported. The membrane phase consists of the tertiary amine carrier Alamine 336 and the surfactant Span 80 dissolved in n-heptane/paraffin and aqueous solutions of sodium carbonate in the internal phase. The effects of internal phase reagent, extraction temperature, and initial external phase pH on the extraction efficiency and the emulsion swelling are examined. A statistical factorial experiment on extraction from clarified lactic acid fermentation broth was carried out to obtain knowledge of the performance of the extraction system from a broth. The extraction efficiency from the fermentation broth is found to be lower as compared to aqueous solutions of pure lactic acid. The effect of pH and the presence of other ionic species on selectivity are discussed. (c) 1993 John Wiley & Sons, Inc.     

Purification of monoclonal antibodies from whole hybridoma fermentation broth by fluidized bed adsorption

To achive the coarse purification of a monoclonal antibody from whole hybridoma fermentation broth a fluidized bed cation exchange process was used. The procedure consisted of application of the crude sample and washing of the bed in a fluidized mode and elution in a fixed bed mode. A completely clarified eluate was obtained with purification factors between 4 and 8 and a concentration of the desired product (monoclonal antibody) by a factor of more than 3 was achived. Thus, a combination of the three early steps of the downstream process clarification, concentration and coarse purification was possible. Two different materials were tested: a commercially available agarose-based matrix (Stream-line-SP), and a self-derivatized material based on controlled-pore glass (Bioran). Initial experiments were performed to describe the fluidization of the glass material. Comparison with the agarose material showed several differences, the agarose matrix allowing liquid flow closer to plug flow than the glass material. Increased backmixing in the liquid phase was detected when fluidizing the glass adsorbent compared with the agarose-based matrix. Despite this fact, comparison of the two materials with respect to antibody binding and elution demonstrated a similar performance. (c) 1995 John Wiley & Sons, Inc.     

Enhanced production of bioethanol from waste of beer fermentation broth at high temperature through consecutive batch strategy by simultaneous saccharification and fermentation

Malt hydrolyzing enzymes and yeast glycolytic and fermentation enzymes in the waste from beer fermentation broth (WBFB) were identified by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). A new ‘one-pot consecutive batch strategy’ was developed for efficient bio-ethanol production by simultaneous saccharification and fermentation (SSF) using WBFB without additional enzymes, microbial cells, or carbohydrates. Bio-ethanol production was conducted in batches using WBFB supernatant in the first phase at 25–67 °C and 50 rpm, followed by the addition of 3% WBFB solid residue to the existing culture broth in the second phase at 67 °C. The ethanol production increased from 50 to 102.5 g/L when bare supernatant was used in the first phase, and then to 219 g ethanol/L in the second phase. The amount of ethanol obtained using this strategy was almost equal to that obtained using the original WBFB containing 25% solid residue at 33 °C, and more than double that obtained when bare supernatant was used. Microscopic and gel electrophoresis studies revealed yeast cell wall degradation and secretion of cellular material into the surrounding medium. Scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) supported the existence of enzymes in WBFB involved in bioethanol production at elevated temperatures. The results of this study will provide insight for the development of new strategies for biofuel production.     

红缘拟层孔菌固体发酵产物体内抗肿瘤和抗氧化作用研究

研究了红缘拟层孔菌固体发酵产物对H22荷瘤小鼠的抗肿瘤和抗氧化作用,以抑瘤率、脾和胸腺指数、白细胞介素-2、干扰素-r、血管内皮细胞生长因子、超氧化物歧化酶、丙二醛、过氧化氢酶、谷胱甘肽过氧化物等指标来考察红缘拟层孔菌固体发酵产物对H22荷瘤小鼠肿瘤抑制和体内抗氧化作用。结果表明,固体发酵产物高剂量和中剂量组的抑瘤率分别为66.66%和64.70%,与阴性组比较,有显著的抗肿瘤作用（P<0.01）,HE染色切片也能观察到固体发酵产物高、中和低各组肿瘤细胞大量坏死,并且高剂量和低剂量组血清中白细胞介素-2和干扰素-r含量显著增加,血管内皮生长因子含量降低,与抑制肿瘤效果具有一定相关性;此外,红缘拟层孔菌固体发酵产物各组可以降低丙二醛含量,提高超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物含量;综上所述,红缘拟层孔菌固体发酵产物具有显著的抗肿瘤和抗氧化作用。